End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.092 AUD | +2.22% | +9.52% | +55.93% |
Jun. 03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.93% | 54.84M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- Percheron Therapeutics Secures US Patent for Muscular Dystrophy Medicinal Candidate